CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Managing Urological Disorders in Multiple Sclerosis Patients: A Review of Available and Emerging Therapies
Riccardo Bientinesi, Carlo Gandi, PierFrancesco Bassi
Int Neurourol J. 2020;24(2):118-126.   Published online 2020 June 30
DOI: https://doi.org/10.5213/inj.2040028.014

Excel Download

Managing Urological Disorders in Multiple Sclerosis Patients: A Review of Available and Emerging Therapies
International Neurourology Journal. 2020;24(2):118-126   Crossref logo
Link1 Link2 Link3

Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis
Multiple Sclerosis and Related Disorders. 2016;9:23-30   Crossref logo
Link1 Link2

Factors influencing patients’ willingness-to-pay for disease-modifying therapies for multiple sclerosis
Multiple Sclerosis and Related Disorders. 2021;48:102720   Crossref logo
Link1 Link2

Emerging Therapies for Multiple Sclerosis
Translational Neuroimmunology in Multiple Sclerosis. 2016;285-304   Crossref logo
Link1 Link2

Pregnancy Outcome in Multiple Sclerosis Patients Exposed to Disease Modifying Therapies
Multiple Sclerosis and Related Disorders. 2020;37:101581   Crossref logo
Link1 Link2

Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis
Multiple Sclerosis and Related Disorders. 2021;103358   Crossref logo
Link1 Link2

Non-compliance with disease modifying therapies in patients with Multiple Sclerosis: A qualitative analysis
Multiple Sclerosis and Related Disorders. 2020;41:102016   Crossref logo
Link1 Link2

COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
Multiple Sclerosis and Related Disorders. 2020;44:102306   Crossref logo
Link1 Link2

Patients’ preferences and willingness-to-pay for disease-modifying therapies
Multiple Sclerosis and Related Disorders. 2019;35:55-60   Crossref logo
Link1 Link2

To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England
Multiple Sclerosis and Related Disorders. 2022;103541   Crossref logo
Link1 Link2